41 related articles for article (PubMed ID: 31731196)
1. p-Hydroxylcinnamaldehyde from cochinchinamomordica seed reverses resistance to TRAIL in human oesophageal squamous cell carcinoma via the activation of the p38 mitogen-activated protein kinase signalling pathway.
Ma M; Zhang C; Xiang XH; Deng XQ; Dai SL; Wei SS; Zhang XM; Zhao LM; Liu YJ; Shan BE
Biomed Pharmacother; 2020 Jan; 121():109611. PubMed ID: 31731196
[TBL] [Abstract][Full Text] [Related]
2. Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy.
Han L; Dai S; Li Z; Zhang C; Wei S; Zhao R; Zhang H; Zhao L; Shan B
J Exp Clin Cancer Res; 2019 Dec; 38(1):501. PubMed ID: 31864387
[TBL] [Abstract][Full Text] [Related]
3. Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation.
Ma Z; Fan C; Yang Y; Di S; Hu W; Li T; Zhu Y; Han J; Xin Z; Wu G; Zhao J; Li X; Yan X
Sci Rep; 2016 Oct; 6():35196. PubMed ID: 27731378
[TBL] [Abstract][Full Text] [Related]
4. Periplcymarin targets glycolysis and mitochondrial oxidative phosphorylation of esophageal squamous cell carcinoma: Implication in anti-cancer therapy.
Han L; Xiang X; Fu Y; Wei S; Zhang C; Li L; Liu Y; Lv H; Shan B; Zhao L
Phytomedicine; 2024 Jun; 128():155539. PubMed ID: 38522311
[TBL] [Abstract][Full Text] [Related]
5. Targeting integrin αvβ3 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma.
Liu F; Wu Q; Han W; Laster K; Hu Y; Ma F; Chen H; Tian X; Qiao Y; Liu H; Kim DJ; Dong Z; Liu K
Clin Transl Med; 2021 Oct; 11(10):e548. PubMed ID: 34709754
[TBL] [Abstract][Full Text] [Related]
6. Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo.
Oikonomou E; Kothonidis K; Taoufik E; Probert E; Zografos G; Nasioulas G; Andera L; Pintzas A
Br J Cancer; 2007 Jul; 97(1):73-84. PubMed ID: 17551494
[TBL] [Abstract][Full Text] [Related]
7. Corynoline inhibits esophageal squamous cell carcinoma growth via targeting Pim-3.
Shi Y; Yuan Q; Chen Y; Li X; Zhou Y; Zhou H; Peng F; Jiang Y; Qiao Y; Zhao J; Zhang C; Wang J; Liu K; Dong Z
Phytomedicine; 2024 Jan; 123():155235. PubMed ID: 38128397
[TBL] [Abstract][Full Text] [Related]
8. Curcumin Sensitizes Kidney Cancer Cells to TRAIL-Induced Apoptosis via ROS Mediated Activation of JNK-CHOP Pathway and Upregulation of DR4.
Obaidi I; Cassidy H; Gaspar VI; McCaul J; Higgins M; Halász M; Reynolds AL; Kennedy BN; McMorrow T
Biology (Basel); 2020 May; 9(5):. PubMed ID: 32370057
[TBL] [Abstract][Full Text] [Related]
9. Daurisoline inhibits proliferation, induces apoptosis, and enhances TRAIL sensitivity of breast cancer cells by upregulating DR5.
Liu X; Wang LL; Duan CY; Rong YR; Liang YQ; Zhu QX; Hao GP; Wang FZ
Cell Biol Int; 2024 Apr; ():. PubMed ID: 38563483
[TBL] [Abstract][Full Text] [Related]
10. Development of targeted therapy of NRF2
Paiboonrungruang C; Simpson E; Xiong Z; Huang C; Li J; Li Y; Chen X
Cell Signal; 2021 Oct; 86():110105. PubMed ID: 34358647
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphene suppresses oesophageal cancer growth through mitogen- and stress-activated kinase 2 in a PDX mouse model.
Zhang C; Wu Q; Yao K; Jin G; Zhao S; Zhang J; Zheng W; Xu B; Zu Y; Yuan J; Liu K; Guo Y
Am J Cancer Res; 2023; 13(10):4708-4720. PubMed ID: 37970356
[TBL] [Abstract][Full Text] [Related]
12. TRAIL DR5-CTSB crosstalk participates in breast cancer autophagy initiated by SAHA.
Han H; Zhou H; Li J; Feng X; Zou D; Zhou W
Cell Death Discov; 2017; 3():17052. PubMed ID: 29018571
[TBL] [Abstract][Full Text] [Related]
13. Activation of endoplasmic reticulum stress by harmine suppresses the growth of esophageal squamous cell carcinoma.
Fan R; Wang S; Wu Y; Feng Y; Gao M; Cao Y; Ma X; Xie S; Wang C; Gao L; Wang Y; Dai F
Phytother Res; 2023 Oct; 37(10):4655-4673. PubMed ID: 37525965
[TBL] [Abstract][Full Text] [Related]
14. Dual targeting of DR5 and VEGFR2 molecular pathways by multivalent fusion protein significantly suppresses tumor growth and angiogenesis.
Isakova AA; Artykov AA; Plotnikova EA; Trunova GV; Khokhlova VА; Pankratov AA; Shuvalova ML; Mazur DV; Antipova NV; Shakhparonov MI; Dolgikh DA; Kirpichnikov MP; Gasparian ME; Yagolovich AV
Int J Biol Macromol; 2024 Jan; 255():128096. PubMed ID: 37972835
[TBL] [Abstract][Full Text] [Related]
15. New withanolides with TRAIL-sensitizing effect from
Chen LX; Xia GY; He H; Huang J; Qiu F; Zi XL
RSC Adv; 2016; 6(58):52925-52936. PubMed ID: 27822364
[No Abstract] [Full Text] [Related]
16. Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78].
Wang WW; Zhao ZH; Wang L; Li P; Chen KS; Zhang JY; Li WC; Jiang GZ; Li XN
EBioMedicine; 2020 May; 55():102772. PubMed ID: 32416443
[No Abstract] [Full Text] [Related]
17. Retraction notice to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78].
Wang WW; Zhao ZH; Wang L; Li P; Chen KS; Zhang JY; Li WC; Jiang GZ; Li XN
EBioMedicine; 2024 May; 103():105105. PubMed ID: 38579362
[No Abstract] [Full Text] [Related]
18. Retraction notice to "Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]" [EBioMedicine 55 (2020) 102772].
Wang WW; Zhao ZH; Wang L; Li P; Chen KS; Zhang JY; Li WC; Jiang GZ; Li XN
EBioMedicine; 2024 May; 103():105106. PubMed ID: 38579361
[No Abstract] [Full Text] [Related]
19. Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial.
Li J; Yu K; Pang D; Wang C; Jiang J; Yang S; Liu Y; Fu P; Sheng Y; Zhang G; Cao Y; He Q; Cui S; Wang X; Ren G; Li X; Yu S; Liu P; Qu X; Tang J; Wang O; Fan Z; Jiang G; Zhang J; Wang J; Zhang H; Wang S; Zhang J; Jin F; Rao N; Ma B; He P; Xu B; Zhuang Z; Wang J; Sun Q; Guo X; Mo M; Shao Z;
J Clin Oncol; 2020 Jun; 38(16):1774-1784. PubMed ID: 32275467
[TBL] [Abstract][Full Text] [Related]
20. P-Hydroxylcinnamaldehyde induces tumor-associated macrophage polarization toward the M1 type by regulating the proteome and inhibits ESCC in vivo and in vitro.
Wang X; Wei S; Li W; Wei X; Zhang C; Dai S; Ma M; Zhao L; Shan B
Int Immunopharmacol; 2023 Jun; 119():110213. PubMed ID: 37137266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
